Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 208697

Expand all

DEFERASIROX (DEFERASIROX)
90MG
Marketing Status: Prescription
Active Ingredient: DEFERASIROX
Proprietary Name: DEFERASIROX
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 90MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A208697
Product Number: 001
Approval Date: Dec 13, 2019
Applicant Holder Full Name: ACTAVIS ELIZABETH LLC
Marketing Status:  Prescription
Patent and Exclusivity Information
DEFERASIROX (DEFERASIROX)
180MG
Marketing Status: Prescription
Active Ingredient: DEFERASIROX
Proprietary Name: DEFERASIROX
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 180MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A208697
Product Number: 002
Approval Date: Dec 13, 2019
Applicant Holder Full Name: ACTAVIS ELIZABETH LLC
Marketing Status:  Prescription
Patent and Exclusivity Information
DEFERASIROX (DEFERASIROX)
360MG
Marketing Status: Prescription
Active Ingredient: DEFERASIROX
Proprietary Name: DEFERASIROX
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 360MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A208697
Product Number: 003
Approval Date: Dec 13, 2019
Applicant Holder Full Name: ACTAVIS ELIZABETH LLC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English